Literature DB >> 26016447

Tumor inoculation site affects the development of cancer cachexia and muscle wasting.

Tatsuzo Matsuyama1, Takeshi Ishikawa1,2, Tetsuya Okayama1,2, Kaname Oka1, Satoko Adachi2, Katsura Mizushima1, Reiko Kimura1, Manabu Okajima1, Hiromi Sakai1, Naoyuki Sakamoto1, Kazuhiro Katada1, Kazuhiro Kamada1, Kazuhiko Uchiyama1, Osamu Handa1, Tomohisa Takagi1, Satoshi Kokura1,3, Yuji Naito1, Yoshito Itoh1.   

Abstract

The phenotype and severity of cancer cachexia differ among tumor types and metastatic site in individual patients. In this study, we evaluated if differences in tumor microenvironment would affect the development of cancer cachexia in a murine model, and demonstrated that body weight, adipose tissue and gastrocnemius muscle decreased in tumor-bearing mice. Interestingly, a reduction in heart weight was observed in the intraperitoneal tumor group but not in the subcutaneous group. We evaluated 23 circulating cytokines and members of the TGF-β family, and found that levels of IL-6, TNF-α and activin A increased in both groups of tumor-bearing mice. Eotaxin and G-CSF levels in the intraperitoneal tumor group were higher than in the subcutaneous group. Atrogin 1 and MuRF1 mRNA expressions in the gastrocnemius muscle increased significantly in both groups of tumor-bearing mice, however, in the myocardium, expression of these mRNAs increased in the intraperitoneal group but not in subcutaneous group. Based on these results, we believe that differences in microenvironment where tumor cells develop can affect the progression and phenotype of cancer cachexia through alterations in various circulating factors derived from the tumor microenvironment.
© 2015 UICC.

Entities:  

Keywords:  cancer cachexia; colorectal cancer; cytokine; muscle wasting; tumor microenvironment

Mesh:

Substances:

Year:  2015        PMID: 26016447     DOI: 10.1002/ijc.29620

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  Prostate cancer reduces endurance exercise capacity in association with reductions in cardiac and skeletal muscle mass in the rat.

Authors:  Peter J Esau; Elizabeth M Gittemeier; Alexander B Opoku-Acheampong; Korynne S Rollins; Dryden R Baumfalk; David C Poole; Timothy I Musch; Bradley J Behnke; Steven W Copp
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

2.  Isoform-specific role of Na/K-ATPase α1 in skeletal muscle.

Authors:  Laura C Kutz; Shreya T Mukherji; Xiaoliang Wang; Amber Bryant; Isabel Larre; Judith A Heiny; Jerry B Lingrel; Sandrine V Pierre; Zijian Xie
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-02-13       Impact factor: 4.310

3.  BAFF and APRIL from Activin A-Treated Dendritic Cells Upregulate the Antitumor Efficacy of Dendritic Cells In Vivo.

Authors:  Michael R Shurin; Yang Ma; Anton A Keskinov; Ruijing Zhao; Anna Lokshin; Marianna Agassandian; Galina V Shurin
Journal:  Cancer Res       Date:  2016-06-30       Impact factor: 12.701

4.  Water-soluble dietary fiber alleviates cancer-induced muscle wasting through changes in gut microenvironment in mice.

Authors:  Tomoki Sakakida; Takeshi Ishikawa; Toshifumi Doi; Ryuichi Morita; Yuki Endo; Shinya Matsumura; Takayuki Ota; Juichiro Yoshida; Yasuko Hirai; Katsura Mizushima; Yasuki Higashimura; Ken Inoue; Tetsuya Okayama; Kazuhiko Uchiyama; Tomohisa Takagi; Aya Abe; Ryo Inoue; Yoshito Itoh; Yuji Naito
Journal:  Cancer Sci       Date:  2022-03-17       Impact factor: 6.518

5.  Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia.

Authors:  Michaela Schäfer; Christian U Oeing; Maria Rohm; Ezgi Baysal-Temel; Lorenz H Lehmann; Ralf Bauer; H Christian Volz; Michael Boutros; Daniela Sohn; Carsten Sticht; Norbert Gretz; Katrin Eichelbaum; Tessa Werner; Marc N Hirt; Thomas Eschenhagen; Karin Müller-Decker; Oliver Strobel; Thilo Hackert; Jeroen Krijgsveld; Hugo A Katus; Mauricio Berriel Diaz; Johannes Backs; Stephan Herzig
Journal:  Mol Metab       Date:  2015-11-26       Impact factor: 7.422

6.  Circulating Activin A predicts survival in cancer patients.

Authors:  Audrey Loumaye; Marie de Barsy; Maxime Nachit; Pascale Lause; Aline van Maanen; Pierre Trefois; Damien Gruson; Jean-Paul Thissen
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-07-15       Impact factor: 12.910

7.  Syngeneic B16F10 Melanoma Causes Cachexia and Impaired Skeletal Muscle Strength and Locomotor Activity in Mice.

Authors:  Fabrício A Voltarelli; Fernando T Frajacomo; Camila de Souza Padilha; Mayra T J Testa; Paola S Cella; Diogo F Ribeiro; Donizete X de Oliveira; Luciana C Veronez; Gabriela S Bisson; Felipe A Moura; Rafael Deminice
Journal:  Front Physiol       Date:  2017-09-29       Impact factor: 4.566

8.  Cancer Cachexia Induces Preferential Skeletal Muscle Myosin Loss When Combined With Denervation.

Authors:  Takashi Yamada; Yuki Ashida; Daisuke Tatebayashi; Masami Abe; Koichi Himori
Journal:  Front Physiol       Date:  2020-04-28       Impact factor: 4.566

9.  MicroRNA-mRNA Co-sequencing Identifies Transcriptional and Post-transcriptional Regulatory Networks Underlying Muscle Wasting in Cancer Cachexia.

Authors:  Geysson Javier Fernandez; Juarez Henrique Ferreira; Ivan José Vechetti; Leonardo Nazario de Moraes; Sarah Santiloni Cury; Paula Paccielli Freire; Jayson Gutiérrez; Renato Ferretti; Maeli Dal-Pai-Silva; Silvia Regina Rogatto; Robson Francisco Carvalho
Journal:  Front Genet       Date:  2020-05-29       Impact factor: 4.599

10.  The Combination of Astragalus membranaceus and Angelica sinensis Inhibits Lung Cancer and Cachexia through Its Immunomodulatory Function.

Authors:  Tsung-Han Wu; Kun-Yun Yeh; Chen-Hsu Wang; Hang Wang; Tsung-Lin Li; Yi-Lin Chan; Chang-Jer Wu
Journal:  J Oncol       Date:  2019-11-03       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.